As indicated in the application, the dosage of the drug for vaccination of children will be 25 mcg versus 100 mcg for adults.

The American company Moderna has sent a request to the U.S. Food and Drug Administration for approval for the emergency use of its coronavirus vaccine for children under the age of six. This is stated in a statement published on Thursday on the company’s website.

“We are proud to announce that we have initiated the procedure for expedited submission for approval of our COVID-19 vaccine for young children,” the statement quoted the head of Moderna Stephane Bancel.

As indicated in the application, the dosage of the drug for vaccination of children will be 25 mcg versus 100 mcg for adults. According to the interim results of the second phase of the vaccine trials, a stable immune response was demonstrated in children from six months to six years old.

The company also announced the submission of similar applications to a number of international regulatory authorities.